Remove Dental marketing Remove Laser dentistry Remove Marketing
article thumbnail

BIOLASE to Report Second Quarter 2023 Results on 8/10/23

Dentistry Today

financial markets. About BIOLASE The company develops, manufactures, markets, and sells laser systems for dentistry and medicine. Their products are designed to advance the practice of dentistry and medicine, providing better outcomes for patients and healthcare professionals.

article thumbnail

BIOLASE Enhances Education Offerings in 2024

Dentistry Today

BIOLASE plans to continue expanding its educational offerings through Education.Biolase.com , enabling dental clinicians to elevate their standard of dental care and improve patient outcomes through laser technology. From 1998 through December 31, 2022, BIOLASE has sold over 45,500 laser systems in over 80 countries worldwide.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BIOLASE to Report First Quarter 2023 Results on May 11

Dentistry Today

financial markets and will host a conference call and webcast that day at 4:30 PM ET / 1:30 PM PT to discuss the results and corporate developments. About BIOLASE The company focuses on medical devices that develop, manufacture, market, and sell laser systems in dentistry and medicine.

article thumbnail

BIOLASE Announces Grand Opening of Training Facility

Dentistry Today

We also expect the hands-on training will give these practitioners greater confidence to adopt our lasers for better patient outcomes while at the same time attracting new patients interested in the enhanced capabilities made possible with dental laser technology.”

article thumbnail

BIOLASE Reports Unaudited Revenue Growth for Full Year 2023 and Provides Outlook for Full Year 2024

Dentistry Today

The company believes it is well-positioned with its industry-leading dental lasers and broad intellectual property (“IP”) portfolio to capitalize on the significant market opportunity for dental laser adoption and, with the year-end cash and cash equivalents balance of $6.6

article thumbnail

BIOLASE Takes Steps to Improve Operating Efficiency

Dentistry Today

BIOLASE is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers. These optimization efforts allow us to focus on our growth and profitability targets without compromising our commitment to customer satisfaction and market expansion.

article thumbnail

BIOLASE Announces 1-for-100 Reverse Stock Split

Dentistry Today

Shortly following the special meeting, the board of directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 PM Eastern Time on July 27, 2023, and the company’s common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023. million shares.